North America Ultrasound Guided Therapy in Minimally Invasive Surgery Market Size, Share, and Trends 2026 to 2035

Payal Rabde, a Healthcare Industry Expert, highlights that the North America ultrasound-guided therapy in minimally invasive surgery market has reached USD 1.56 billion in 2026 and is on track to reach USD 3.62 billion by 2035, advancing at a CAGR of 9.80%. Key North America ultrasound-guided therapy in minimally invasive surgery market companies shaping the market include Medtronic, HistoSonics, Boston Scientific, INSIGHTEC, while major growth segments span technology, component, application, end user.

Last Updated : 16 Nov 2026  |  Report Code : 8973  |  Category : Healthcare   |  Format : PDF / PPT / Excel

1. Market Overview & Sizing

1.1 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market: Definition and Scope

1.1.1 Market Definition and Scope of Study

1.1.2 Inclusions and Exclusions

1.1.3 Currency, Units and Base Year

1.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Taxonomy

1.2.1 By Technology

1.2.2 By Component

1.2.3 By Application

1.2.4 By End User

1.3 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Size and Forecast, 2025-2035

1.3.1 Market Value (USD) and Annual Growth

1.3.2 Historical Market Analysis

1.3.3 Market Growth Analysis and CAGR 2026-2035

1.4 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Penetration and Maturity Analysis

1.5 Addressable Market Analysis (TAM, SAM, SOM) for North America Ultrasound-Guided Therapy in Minimally Invasive Surgery

1.6 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Value Chain Analysis

1.7 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Ecosystem Analysis

2. Market Dynamics & Opportunities

2.1 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Dynamics Overview

2.2 Growth Drivers

2.2.1 Cancer incidence rises

2.2.2 Patients prefer non-invasive options

2.2.3 Outcomes data improve

2.2.4 Outpatient care grows

2.3 Market Drivers - Impact & CAGR Contribution (2026-2035)

2.4 Market Restraints

2.4.1 High system costs

2.4.2 Limited reimbursement for new methods

2.4.3 Training needs

2.4.4 Competition from surgery and radiation

2.5 Market Restraints - Impact & Negative CAGR Contribution (2026-2035)

2.6 Market Challenges

2.7 Emerging Opportunities

2.7.1 Kidney and pancreas indications

2.7.2 Focal prostate therapy

2.7.3 ASC adoption

2.7.4 Neurological indications

2.8.1 Non-thermal histotripsy

2.8.2 Focal therapy for prostate cancer

2.8.3 Outpatient tumor ablation

2.8.4 AI-assisted targeting and fusion imaging

2.8.5 Robotic ultrasound delivery

2.8.6 New reimbursement codes

2.9 Unmet Needs, White Space and Gap Analysis

2.10 Industry Evolution and Transformation of the North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market

3. Segmentation & Forecast

3.1 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market, by Technology (Share %, 2025-2035)

3.1.1 Ultrasound-Guided Thermal Ablation (RF & Microwave): Market Share and CAGR

3.1.2 High-Intensity Focused Ultrasound (HIFU): Market Share and CAGR

3.1.3 Histotripsy: Market Share and CAGR

3.1.4 Ultrasound-Guided Interventional & Others: Market Share and CAGR

3.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market, by Component (Share %, 2025-2035)

3.2.1 Systems: Market Share and CAGR

3.2.2 Consumables & Probes: Market Share and CAGR

3.2.3 Services: Market Share and CAGR

3.3 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market, by Application (Share %, 2025-2035)

3.3.1 Oncology: Market Share and CAGR

3.3.2 Urology: Market Share and CAGR

3.3.3 Gynecology: Market Share and CAGR

3.3.4 Neurology & Pain Management: Market Share and CAGR

3.3.5 Others: Market Share and CAGR

3.4 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market, by End User (Share %, 2025-2035)

3.4.1 Hospitals: Market Share and CAGR

3.4.2 Ambulatory Surgical Centers: Market Share and CAGR

3.4.3 Specialty Clinics: Market Share and CAGR

3.5 Segment Attractiveness and Growth Comparison

4. Regional & Country Intelligence

4.1 U.S. Ultrasound-Guided Therapy in Minimally Invasive Surgery Market

4.1.1 Market Size and Forecast, 2025-2035

4.1.2 Market Share by Technology

4.1.3 Demand Drivers, Regulation and Local Competition

4.2 Canada Ultrasound-Guided Therapy in Minimally Invasive Surgery Market

4.2.1 Market Size and Forecast, 2025-2035

4.2.2 Market Share by Technology

4.2.3 Demand Drivers, Regulation and Local Competition

4.3 Mexico Ultrasound-Guided Therapy in Minimally Invasive Surgery Market

4.3.1 Market Size and Forecast, 2025-2035

4.3.2 Market Share by Technology

4.3.3 Demand Drivers, Regulation and Local Competition

4.4 Country Attractiveness and Market Entry Assessment

5. Competitive & Company Intelligence

5.1 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Competitive Landscape Overview

5.2 Market Share by Company, 2025

5.3 Company Ranking and Competitive Indexing

5.4 Precedence Research Companies Quadrant

5.5 Competitive Benchmarking

5.5.1 Product Portfolio Benchmarking

5.5.2 Geographic Presence Benchmarking

5.5.3 Technology and Innovation Benchmarking

5.6 Strategic Group Mapping

5.7 Barriers to Entry and New Entrant Analysis

5.8 Mergers, Acquisitions and Strategic Partnerships

5.9 Recent Developments in the North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market

6. Pricing Intelligence

6.1 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Pricing Overview

6.1.1 Average selling price by product and procedure type

6.1.2 Hospital contract and group purchasing organization (GPO) pricing

6.1.3 Reimbursement-linked pricing and DRG impact

6.1.4 Premium vs. value-tier device pricing

6.2 Pricing by Technology

6.3 Pricing by Country

6.4 Historical Price Trend and Price Forecast, 2025-2035

6.5 Cost Structure, Margin and Price Sensitivity Analysis

6.6 Competitor Pricing Benchmarking

7. Buyer & Customer Intelligence

7.1 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Buyer Landscape

7.1.1 Hospitals and integrated delivery networks

7.1.2 Ambulatory surgical centers and specialty clinics

7.1.3 Group purchasing organizations and tender bodies

7.1.4 Clinician (KOL) influence on device selection

7.2 Buyer Segmentation and Purchasing Patterns

7.3 Buying Criteria and Decision-Making Process

7.4 Customer Pain Points and Unmet Needs

7.5 Customer Retention, Switching and Loyalty Analysis

8. Buying, Selling & Procurement

8.1 Procurement Strategies and Supplier Selection Criteria

8.2 Sales Channel Analysis: Direct vs. Indirect

8.3 Distributor and Dealer Network Analysis

8.4 Key Account and Contract Analysis

8.5 Cross-Selling and Upselling Opportunities

9. Supply Chain & Manufacturing

9.1 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Supply Chain Mapping

9.1.1 Raw materials and component suppliers

9.1.2 Contract manufacturers and sterilization providers

9.1.3 Distribution through medical device distributors

9.1.4 Hospital inventory and consignment models

9.2 Supplier Landscape and Concentration

9.3 Manufacturing Footprint and Capacity Analysis

9.4 Supply Chain Risk and Resilience

10. Trade & Distribution

10.1 Import and Export Analysis

10.2 Major Exporting and Importing Countries

10.3 Tariffs, Duties and Trade Regulations

10.4 Distribution Channel Share and E-commerce Analysis

11. Technology & Innovation

11.1 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Technology Landscape

11.1.1 Next-generation device design and materials

11.1.2 Imaging, navigation and digital integration

11.1.3 AI-enabled clinical decision support

11.1.4 Patent landscape and freedom-to-operate

11.2 Innovation Pipeline and R&D Investment Analysis

11.3 Technology Adoption and Readiness Analysis

11.4 Future Technology Roadmap

12. Regulatory & Risk

12.1 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Regulatory Landscape

12.1.1 FDA 510(k), De Novo and PMA pathways

12.1.2 EU MDR certification and notified body capacity

12.1.3 Clinical evidence and post-market surveillance requirements

12.1.4 Recalls, safety notices and quality system risks

12.2 Regulatory Risk and Compliance Cost Analysis

12.3 Political, Economic and Supply Risk Assessment

13. Investment & Financial

13.1 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market Investment Landscape

13.2 Funding, Venture Capital and Private Equity Activity

13.3 M&A Landscape and Valuation Benchmarking

13.4 Revenue Pool and Profit Pool Analysis

13.5 Investment Opportunity Mapping

14. GTM & Commercial Strategy

14.1 Market Entry and Expansion Strategy

14.2 Go-to-Market Strategy by Customer Segment

14.3 Partnership and Commercialization Opportunities

14.4 Opportunity Prioritization Matrix

15. Advanced Forecasting & Scenarios

15.1 Scenario-Based Forecast for the North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market (Base, Optimistic, Pessimistic)

15.2 Sensitivity Analysis of Key Assumptions

15.3 Demand-Supply Gap Forecast

15.4 Market Risk and Uncertainty Assessment

15.5 Long-Term Market Outlook to 2035

16. Industry-Specific Intelligence: Medical Device

16.1 Procedure volume analysis

16.2 Patient pool and disease prevalence

16.3 Clinical evidence and guideline adoption

16.4 Reimbursement landscape by country

16.5 Installed base and replacement cycle analysis

16.6 Hospital adoption and utilization analysis

17. Company Profiles & Benchmarking

17.1 Medtronic

17.1.1 Company Overview

17.1.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Product Portfolio

17.1.3 Financial Performance and Market Share

17.1.4 Recent Developments and Strategy

17.1.5 SWOT Analysis

17.2 HistoSonics

17.2.1 Company Overview

17.2.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Product Portfolio

17.2.3 Financial Performance and Market Share

17.2.4 Recent Developments and Strategy

17.2.5 SWOT Analysis

17.3 Boston Scientific

17.3.1 Company Overview

17.3.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Product Portfolio

17.3.3 Financial Performance and Market Share

17.3.4 Recent Developments and Strategy

17.3.5 SWOT Analysis

17.4 Insightec

17.4.1 Company Overview

17.4.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Product Portfolio

17.4.3 Financial Performance and Market Share

17.4.4 Recent Developments and Strategy

17.4.5 SWOT Analysis

17.5 EDAP TMS

17.5.1 Company Overview

17.5.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Product Portfolio

17.5.3 Financial Performance and Market Share

17.5.4 Recent Developments and Strategy

17.5.5 SWOT Analysis

17.6 Johnson & Johnson MedTech

17.6.1 Company Overview

17.6.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Product Portfolio

17.6.3 Financial Performance and Market Share

17.6.4 Recent Developments and Strategy

17.6.5 SWOT Analysis

17.7 SonaCare Medical

17.7.1 Company Overview

17.7.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Product Portfolio

17.7.3 Financial Performance and Market Share

17.7.4 Recent Developments and Strategy

17.7.5 SWOT Analysis

17.8 AngioDynamics

17.8.1 Company Overview

17.8.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Product Portfolio

17.8.3 Financial Performance and Market Share

17.8.4 Recent Developments and Strategy

17.8.5 SWOT Analysis

17.9 GE HealthCare

17.9.1 Company Overview

17.9.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Product Portfolio

17.9.3 Financial Performance and Market Share

17.9.4 Recent Developments and Strategy

17.9.5 SWOT Analysis

17.10 Profound Medical

17.10.1 Company Overview

17.10.2 North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Product Portfolio

17.10.3 Financial Performance and Market Share

17.10.4 Recent Developments and Strategy

17.10.5 SWOT Analysis

18. Strategic Recommendations

18.1 Recommendations for Manufacturers and Suppliers in the North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market

18.2 Recommendations for Investors

18.3 Recommendations for Buyers and End Users

18.4 Key Success Factors

19. Analyst View & FAQs

19.1 Analyst View on the North America Ultrasound-Guided Therapy in Minimally Invasive Surgery Market

19.2 Research Methodology and Data Validation

19.3 Frequently Asked Questions

19.4 Sources and Abbreviations

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The North America ultrasound-guided therapy in minimally invasive surgery market was valued at USD 1.42 billion in 2025 and is estimated at USD 1.56 billion in 2026. It is projected to reach USD 3.62 billion by 2035.

Answer : The North America ultrasound-guided therapy in minimally invasive surgery market is expected to grow at a CAGR of 9.80% from 2026 to 2035, driven by new indications, outpatient migration, rising cancer cases, and patient preference for non-invasive treatment.

Answer : Ultrasound-Guided Thermal Ablation (RF & Microwave) leads the North America ultrasound-guided therapy in minimally invasive surgery market with a 41.00% share in 2025, because radiofrequency and microwave ablation of liver, kidney, thyroid, and lung tumors are widely reimbursed.

Answer : U.S. dominates the North America ultrasound-guided therapy in minimally invasive surgery market with a 90.00% share in 2025, while Mexico is the fastest-growing country.

Answer : Key players in the North America ultrasound-guided therapy in minimally invasive surgery market include Medtronic, HistoSonics, Boston Scientific, INSIGHTEC, EDAP TMS, Johnson & Johnson MedTech, SonaCare Medical, AngioDynamics, GE HealthCare, and Profound Medical.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client